Document Detail


A unique class of duocarmycin and CC-1065 analogues subject to reductive activation.
MedLine Citation:
PMID:  18020335     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
N-Acyl O-amino phenol derivatives of CBI-TMI and CBI-indole2 are reported as prototypical members of a new class of reductively activated prodrugs of the duocarmycin and CC-1065 class of antitumor agents. The expectation being that hypoxic tumor environments, with their higher reducing capacity, carry an intrinsic higher concentration of "reducing" nucleophiles (e.g., thiols) capable of activating such derivatives (tunable N-O bond cleavage) and increasing their sensitivity to the prodrug treatment. Preliminary studies indicate the prodrugs effectively release the free drug in functional cellular assays for cytotoxic activity approaching or matching the activity of the free drug, yet remain essentially stable and unreactive to in vitro DNA alkylation conditions (<0.1-0.01% free drug release) and pH 7.0 phosphate buffer, and exhibit a robust half-life in human plasma (t1/2 = 3 h). Characterization of a representative O-(acylamino) prodrug in vivo indicates that they approach the potency and exceed the efficacy of the free drug itself (CBI-indole2), indicating that not only is the free drug effectively released from the inactive prodrug but also that they offer additional advantages related to a controlled or targeted release in vivo.
Authors:
Wei Jin; John D Trzupek; Thomas J Rayl; Melinda A Broward; George A Vielhauer; Scott J Weir; Inkyu Hwang; Dale L Boger
Related Documents :
9724905 - Formulation and in vitro evaluation of ibuprofen-carbopol 974p-nf controlled release ma...
7494815 - Diffusion in hpmc gels. i. determination of drug and water diffusivity by pulsed-field-...
18446485 - Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo e...
12100855 - Floating microparticles based on low density foam powder.
9269495 - In vitro-in vivo relationships of several "immediate" release tablets containing a low ...
6152635 - Benzodiazepine dependence potential: current studies and trends.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2007-11-17
Journal Detail:
Title:  Journal of the American Chemical Society     Volume:  129     ISSN:  1520-5126     ISO Abbreviation:  J. Am. Chem. Soc.     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-12-06     Completed Date:  2008-02-11     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  7503056     Medline TA:  J Am Chem Soc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  15391-7     Citation Subset:  IM    
Affiliation:
Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alkylation / drug effects
Animals
Antibiotics, Antineoplastic / chemistry,  pharmacology*
Cell Line, Tumor
DNA / drug effects,  metabolism
Humans
Indoles / chemistry,  pharmacology*
Inhibitory Concentration 50
Leukemia L1210 / drug therapy
Mice
Mice, Inbred DBA
Phenols / chemistry,  pharmacology
Prodrugs / pharmacology*
Grant Support
ID/Acronym/Agency:
CA41986/CA/NCI NIH HHS; R01 CA041986-20A1/CA/NCI NIH HHS; R01 CA041986-24/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/Indoles; 0/Phenols; 0/Prodrugs; 69866-21-3/CC 1065; 9007-49-2/DNA
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Asymmetric allylboration of acyl imines catalyzed by chiral diols.
Next Document:  Gas-phase models for catalysis: alkane activation and olefin epoxidation by the triatomic cation Ag2...